SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Net Income ScalingExpanding
Percentile Rank100
3Y CAGR+49.5%
5Y CAGR+23.8%
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

3Y CAGR
+49.5%/yr
vs +10.9%/yr prior
5Y CAGR
+23.8%/yr
Recent acceleration
Acceleration
+38.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$109.29B+14.1%
2024$95.76B+13.0%
2023$84.74B+158.9%
2022$32.73B+12.7%
2021$29.04B-22.9%
2020$37.65B+41.3%
2019$26.65B+23.3%
2018$21.62B-69.0%
2017$69.64B+47.7%
2016$47.16B-